7Culley C M, Lacy M K, Klutman N, et al. Moxifloxacin: clinical efficacy and safety[J]. Am J Health Syst Pharm, 2001, 58(5) :379-388.
8Ball P. Aderse drug reactions implications for rhe development of flu inquinolones [J]. J antim iclob Chemother, 2003, 51 ( Suppl 1 ) : 21-27.
9Adams M, Tacakoli H.Gatifloxacin-induced haUuc inactions in a19-year-old man[J]. Psychosomatics, 2006, 47(4) : 360.
10Faith GA,Morgamroth J,Whitehouse AB,et al. Clinical experience with moxifloxacin in patients with respiratory tract infections[J]. The Annals of Pharmaeotherapy, 2004,38(5 ) : 749.
